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Background
Stroke readmissions represent a significant source of morbidity, mortality and healthcare 
spending. According to statistics from the Centers of Disease Control and Prevention 
(CDC), someone suffers a stroke every 40 seconds in the United States, and 
approximately 795,000 individual events occur annually.1All-cause readmissions 
account for $26 billion in healthcare spending per year, which prompted creation of the 
Medicare Hospital Readmission Reduction Program as a component of the Affordable 
Care Act in 2012. This legislation standardized the 30-day window after discharge as a 
target for readmission improvement.2
Previous literature utilizing the Nationwide Readmissions Database showed that between 
11.98 – 13.47% of stroke patients are readmitted within 30 days of discharge.3A separate 
study considering Medicare fee-for-service records found a 14.4% readmission rate 
among the publicly insured.4
Transitions of care (TOC) is a means of providing continuity from one setting or level of 
care to another through strategic counselling. Previous studies have shown that TOC 
clinic follow-up visits are an effective means of reducing all-cause readmissions for a 
variety of chronic conditions including congestive heart failure, asthma, diabetes and 
depression.5A previous study looking specifically at 30-day stroke readmissions among 
the Medicare fee-for-service population showed a slight improvement in the hazard ratio 
when employing TOC clinic with either a neurologist or primary care physician.6
Study goals: 
v Aim 1: Examine if there is a difference between 30-day stroke readmission rate when 
employing TOC clinic and the reported national average.
v Aim 2: Examine if there is a difference between 30-day stroke readmission rate when 
employing TOC clinic and the TJUH average with TOC patients removed.
v Aim 3: Determine if in-patient TOC clinic and telemedicine TOC clinic elicit 
different results in terms of 30-day stroke readmission rate at TJUH.
v Aim 4: Examine patient reported survey measures (self-efficacy, confidence, 
perceived TOC value) to guide improvements. 
Methods
Results
Preliminary analysis included 208 individuals (95 in-person, 113 telemedicine). Our 
results showed that among these patients, 12 (5.8%) experienced all-cause readmissions 
within 30 days of hospital discharge. Of the 12 patients readmitted, 2 were seen in-person 
(2.1%) and 10 were seen via telemedicine (8.8%). Chi Square revealed a between group 
difference (X2 = 4.318, p = 0.038). 
Participants in both the in-person group (u = 8.421, SD = 1.835) and telemedicine group 
(u = 8.100, SD = 1.875) considered TOC a valuable experience. Analysis of perceived 
TOC value did not differ between groups (t = 0.654, p = 0.515). Measures of patient 
confidence (before TOC clinic versus after) are still being conducted and will be 
analyzed using a paired samples t-test. 
Discussion
TOC clinic has been shown to be efficacious for reducing 30-day readmissions for 
numerous chronic conditions. However, there is a dearth of literature reflecting its utility 
with stroke. Our initial results are extremely encouraging when comparing our derived 
30-day readmission rates with those reported in previous publications. Our combined 
figure (5.8%) as well as individual telemedicine (8.8%) and in-person (2.1%) 
readmission numbers outperform those most recently published by the CMS (11.8%) 
from 2015-16 (see graph).7
The difference between in-person and telemedicine TOC readmission statistics might be 
explained by numerous different factors. Telemedicine data was predominantly collected 
during the height of the coronavirus pandemic. Patients may have been experiencing 
worse overall health due to limited access to medical care, isolation and fewer 
opportunities for exercise. Because telemedicine clinic can be conducted from home, it 
may capture patients who would forego in-person clinic due to various personal barriers 
(apathy, time, transportation). These patients may also be less adherent to their treatment 
regimens. Navigating novel technology is challenging for many individuals. The added 
complexity of using a virtual platform may detract from the ability to absorb information 
and result in poorer adherence to therapies. Further research into perceived barriers 
should be conducted.
We have ascertained evidence for two of our aims (1 & 3) thus far. We are awaiting 
queries from TJUH data managers to explore aim 2. More samples incorporating 
confidence measures are currently being collected to allow us to perform a meaningful 
analysis for aim 4.
Limitations & Future Directions
Limitations:
v Telemedicine TOC was not initially a component of the project charter, thus the 
sample size when considering each group individually is smaller than intended
v Patients may experience recall bias when answering telephone survey questions
v Nationally representative figures have not been updated annually and may not reflect 
current trends
Future Directions:
v Translate findings into practical institutional policy
v Perform qualitative study of perceived barriers to telemedicine stroke clinic to make 
platform more accessible
v Repeat study parameters in post-covid era to determine if pandemic confounded 
findings
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Our study seeks to build on previous literature by exploring the efficacy of TOC clinic for 
reducing stroke readmission at Thomas Jefferson University Hospital (TJUH), a certified 
comprehensive stroke center in Philadelphia. We are utilizing a prospective cohort study 
design. Potential participants were identified at TJUH beginning in January of 2019 by 
ICD-10 codes corresponding with various ischemic and hemorrhagic stroke diagnoses. 
Patients were initially automatically scheduled for an in-clinic TOC appointment with a 
vascular neurologist or clinical nurse practitioner within 1 to 3 weeks of hospital discharge. 
When coronavirus precautions were implemented at TJUH in February of 2021, these visits 
were transitioned to telemedicine appointments. 
Goals of these visits:
v Clarify diagnosis and treatment plan
v Improve medication adherence by reinforcing appropriate use
v Assuage fears from discharge
Telephone follow-up surveys are administered to TOC participants within 6 months of their 
visit. These questionnaires employ measures of self-efficacy, confidence and perceived 
value of TOC clinic. Individual survey items were assessed for validity by all team 
members prior to clinical implementation. 30-day readmission rates are collected from 
individual patient electronic health records. All patient data is collected and stored in a 
password-protected living document that can only be accessed by the three team members 
actively recording data for the project. Data analysis is being conducted on a Macintosh 
computer (OS 10.15.5) using IBM SPSS (version 27). 
Measures of patient confidence (before TOC clinic versus after) were added to the survey 
in December of 2020 and are still being collected. When a sufficient sample size has been 
achieved, we will analyze this using a paired samples t-test. An annual TJUH 30-day stroke 
readmission dataset is being prepared with TOC patients removed to enable internal 
comparison. When preparation is complete, we will compare our final TOC figures to 
TJUH standard of care home discharge rates as well as a nationally representative sample 
based on the most recently published Medicare/Medicaid stroke readmission data from the 
Centers of Medicare and Medicaid Services (CMS). This analysis will be performed using 
one sample z-test in excel.
